Chemistry Nobel 2026: How Kagan and Soai Taught Chemistry to Amplify a Tiny Molecular Bias

The Prize Is for Amplification: How a Whisper of Handedness Becomes a Shout

Here's what's actually happening. Many drug molecules come in two versions that are mirror images, like your left and right hands. They contain the same atoms joined in the same order and differ only in their three-dimensional arrangement.

Your body can tell them apart because its enzymes and receptors are themselves handed. A right-handed glove only fits a right hand. Ordinary chemistry, however, cannot tell them apart. Make a chiral molecule in a flask and you usually get a 50:50 mix, called a racemic mixture.

For a drug manufacturer, that means half the batch may be useless or harmful. Kagan and Soai did not solve this by making chemistry perfectly selective. They showed that a small bias can be made to grow.

Kagan: When

60:40 Does Not Stay 60:40 A catalyst is a substance that speeds up a reaction without being used up. If the catalyst is itself chiral, it tilts the reaction towards one handedness. For decades chemists assumed this relationship was linear: a catalyst that is only slightly biased would give products that are only slightly biased.

In 1986 Kagan showed that this assumption is wrong. A mildly chiral catalyst can produce a far more lopsided product.

A way to picture it: imagine a room of 60 left-handed and 40 right-handed people told to pair up. Suppose mixed pairs are the most stable and simply sit down and do nothing. Forty mixed pairs form and the 20 people left standing are all left-handed. Those 20 do all the work. The minority has been taken out of play and the catalyst that actually runs the reaction is far purer than the batch you started with.

Where the picture breaks: real molecules do not pair this neatly. The effect depends on how stable and how reactive each kind of pair is and in some systems it runs the other way and reduces selectivity. The central idea still holds: the link between input and output is not proportional.

Soai: A Molecule That Copies Its Own Handedness

Soai went a step further with autocatalysis, a reaction in which the product acts as the catalyst for making more of itself. He built one that was also asymmetric. A product molecule with one handedness speeds up the formation of more molecules with that same handedness and each of those then does the same.

It behaves like a photocopier that copies only left hands. A slight early lead compounds until the final product reached 99.5% of one form. Before this, only biological processes had produced a single enantiomer this completely.

Why a Pharma Student Should Care -

Safety: the wrong enantiomer of a chiral drug can be inactive or harmful.

• Cost: the older route was to make both forms and separate them. Separation is expensive and wasteful and it can never return more than half the batch as the wanted form.
• Reach: asymmetric synthesis is now used for flavours, fragrances and pesticides, as well as drugs. There is one honest caveat. Soai's specific reaction is a proof of principle, not the routine factory method. What changed manufacturing is the principle both laureates established: you do not need a perfect starting point, only one that can be amplified.